Eiger BioPharmaceuticals, Inc.
Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis

Abstract:

In one aspect, methods of treating non-alcoholic steatohepatitis (NASH) or preventing or delaying the progression of non-alcoholic fatty liver disease (NAFLD) to NASH are provided. In some embodiments, the method comprises administering a therapeutically effective amount of ubenimex.